Register Today for IQVIA’s Tuesday Webinar on Surrogate Endpoints in Oncology Clinical Trials
The IQVIA Institute for Human Data Science will host a webinar at 10:00 AM EDT on Tuesday, August 17th on [...]
Cytel Strategist Discusses Clinical Trial Design and When to Include Interim Looks
Interim looks allow for sponsors of clinical trials to consider whether the trial should continue or if any modifications need [...]
Cytel Consultant Discusses Using Rolling-Enrollment to Speed Up Clinical Trials, Reduce Costs, and Improve Patient Safety
In the traditional clinical trial model, patients are enrolled in a clinical trial and then the effects of a treatment [...]
Why Are Drug Manufacturers Disregarding Clinical Trial Transparency Regulations?
A recent study found that most pharmaceutical companies do not meet rules demanding transparency in clinical trials. This lack of [...]
Updated FDA Guidance Recommends Inclusion of Patients with Incurable Cancers in Clinical Trials
The Food and Drug Administration (FDA) has issued draft guidance instructing clinical trial sponsors to include patients with incurable cancers [...]
Part 2 of Cytel’s Webinar on Considerations for SCAs in Clinical Trials Now Available
A new webinar offered by Cytel details important considerations for researchers seeking to create synthetic control arms (SCAs) using real [...]
Cytel Paper on De-Risking Clinical Trials Using a Data-Driven Method
Cytel has published a position paper on using data to de-risk clinical trials. The paper discusses methods that can be [...]
Cytel Data Expert Discusses EHR Integration in Clinical Trials
Associate Director Business Development at Cytel and chair of the eDigital data management expert group Lauren Ellis-Hill discusses her thoughts [...]
Cytel Webinar on Understanding Synthetic Control Arms and Avoiding HTA Rejection
A recent Cytel webinar clarifies common misunderstandings regarding synthetic control arms (SCAs). The use of real world data (RWD) to [...]
Cytel Webinar on Clinical Trial Design Considerations for Sponsors
Cytel is offering an on-demand webinar that details key considerations for clinical trial sponsors. In addition to examining the downsides [...]
Upcoming Conference on Healthcare Trends Includes Discussions on COVID-19 Impact, FDA Guidelines, and Clinical Trials
An upcoming virtual conference will focus on healthcare trends based on insight from leading digital health experts. It will take [...]
RWE Replicates Randomizes Controlled Trial Findings as FDA Leaders Discuss Decision-Making Trends
Researchers were able to utilize real world evidence (RWE) to reproduce findings from a type 2 diabetes randomized controlled trial. [...]
[Whitepaper] Sensors Provide Useful RWD in Clinical Trials
The use of sensors and wearables in clinical trials is rapidly increasing, a trend that has been accelerated by the [...]
Cytel Article Highlights Common Clinical Trial Pitfalls and Solutions
Cytel has published a non-technical paper that highlights common statistical challenges that lead to sub-optimal clinical trial design. Study design [...]
Johnson & Johnson RWE Expert Shares Thoughts on Transparency
In a recent interview, Jesse Berlin of Johnson & Johnson discusses how real world evidence (RWE) has shifted the research [...]
HealthVerity RWD Use Case Now Available
The use of real world data (RWD) in the synthetic control arm in clinical trials is becoming essential. HealthVerity provides [...]
FDA Office of Health Equity Leader Discusses Diversity in Clinical Trials
Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) at the FDA RADM [...]
Aetion Announces $212 Million in Total Funding as RWE Momentum Builds
Aetion raised an additional $110 million in Series C funding, making its total funding $212 million. The real world evidence [...]
New Guide on Successfully Using RWE in Drug Development Pipeline
Using real world evidence (RWE) continues to be a valuable alternative to the traditional clinical trial. A new guide from [...]
New Article Discusses 35 Oncology Drugs Receiving Accelerated Approval
An article published in the New England Journal of Medicine (NEJM) discusses 35 oncology drugs that received accelerated approval from [...]
BCG Report on Using RWE in Clinical Trials
A Boston Consulting Group (BCG) report discusses the benefits of real world evidence (RWE) in streamlining the clinical trial pipeline. [...]
Aetion Analyst Discusses Using RWE in Rare Disease Clinical Trials
Senior Scientific Analyst Adina Estrin at Aetion discusses how RWE (real world evidence) can be used in constructing external control [...]
Cytel Research Specialist Discusses Benefits of Bayesian Network Models for Clinicians and Clinical Trials
A recent Cytel paper, published in JCO Clinical Cancer Informatics, uses a Bayesian Network Model to accurately predict outcomes in cancer [...]
HealthVerity Clinical Trial Optimization Approach Considers RWD Advantages and Promotes Equity
RWD (real world data) is changing the way clinical trials are designed and conducted. HealthVerity discusses important consideration for using [...]
Cytel Scientist Discusses Clinical Trial Statistical Success Strategies
Cytel scientist Dr. Yannis Jemiai discusses important statistical considerations critical for clinical trial success. Communication at all levels of the [...]